Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfenex Inc (NYSE American:PFNX)

2.14
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
2.07
Today|||52-Week Range
9.79
-76.41%
Year-to-Date
No recent news for Pfenex Inc.

Today’s Trading

Previous close2.14
Today’s open2.25
Day’s range2.10 - 2.26
Volume60,949
Average volume (3 months)98,274
Market cap$50.4M
Data as of 8:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-904.35%
Earnings growth (next 5 years)--
Revenue growth (last year)+528.13%
P/E ratioNM
Price/Sales3.57
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
SRRASierra Oncology Inc0.000.00%
CYTRCytRx Corp0.000.00%
ADMAADMA Biologics Inc0.000.00%
CFRXContraFect Corp0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 19, 2018
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$60.2M
Annual profit (last year)$5.5M
Net profit margin9.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
Evert Schimmelpennink
Chief Medical Officer
Hubert C. Chen
Corporate headquarters
San Diego, California

Forecasts